Details for New Drug Application (NDA): 077656
✉ Email this page to a colleague
The generic ingredient in THRIVE is nicotine polacrilex. There are thirty drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.
Summary for 077656
Tradename: | THRIVE |
Applicant: | Glaxosmithkline Cons |
Ingredient: | nicotine polacrilex |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | GUM, CHEWING;BUCCAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Jun 19, 2007 | TE: | RLD: | No |
Complete Access Available with Subscription